Beta-Thalassemia Major with Secondary Hemochromatosis and Concomitant Systemic Lupus Erythematosus
Annals of Rheumatology and Autoimmunity · 2026-07 · 6 (3) · 121-126
DOI: 10.4103/ara.ara_32_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Rheumatology and Autoimmunity, online erschienen am 28.07.2026. Verfasst von Asmaa Hegazy und 2 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse clinical manifestations and multiorgan involvement. Beta-thalassemia (β-thalassemia) major is a hereditary hemoglobinopathy characterized by the absence of beta-globin chain synthesis, ineffective erythropoiesis, and lifelong transfusion dependence with secondary hemochromatosis. The coexistence of SLE with β-thalassemia major is rare, presenting a diagnostic and therapeutic challenge. We report the case of a 20-year-old female with known transfusion-dependent β-thalassemia major since infancy, who presented with worsening symptomatic anemia, inflammatory polyarthritis, and mucocutaneous manifestations. She had received numerous regular blood transfusions without iron chelation therapy. Based on the 2019 American College of Rheumatology/European League Against Rheumatism classification criteria, the patient was diagnosed with SLE; furthermore, a diagnosis of secondary hemochromatosis was established based on radiological evidence of hepatic iron deposition and laboratory values consistent with iron overload. The treatment included multiple disease-targeted therapies and supportive multidisciplinary care. Clinicians should maintain a high index of suspicion for autoimmune diseases in patients with thalassemia who develop atypical nonspecific manifestations. An unexplained increase in the frequency of required blood transfusions should prompt evaluation for a concomitant systemic disorder. This case underscores the diagnostic complexity and potential immunologic interplay between β-thalassemia, chronic iron overload, and autoimmunity, highlighting the importance of early recognition and a multidisciplinary approach to optimize patient outcomes.
Zitieren
APA
Hegazy, A., Alhamdan, A., & Alnofal, W. (2026). Beta-Thalassemia Major with Secondary Hemochromatosis and Concomitant Systemic Lupus Erythematosus. Annals of Rheumatology and Autoimmunity, 6(3), 121-126. https://doi.org/10.4103/ara.ara_32_25
Vancouver
Hegazy A, Alhamdan A, Alnofal W. Beta-Thalassemia Major with Secondary Hemochromatosis and Concomitant Systemic Lupus Erythematosus. Annals of Rheumatology and Autoimmunity. 2026;6(3):121-126. doi:10.4103/ara.ara_32_25
BibTeX
@article{Hegazy2026,
author = {Hegazy, Asmaa and Alhamdan, Ali and Alnofal, Wafa},
title = {Beta-Thalassemia Major with Secondary Hemochromatosis and Concomitant Systemic Lupus Erythematosus},
journal = {Annals of Rheumatology and Autoimmunity},
year = {2026},
volume = {6},
number = {3},
pages = {121--126},
doi = {10.4103/ara.ara_32_25}
}
EUVIMED